Frankfurt - Delayed Quote EUR
HBM Holdings Limited (6XY.F)
0.9000
+0.0500
+(5.88%)
At close: April 25 at 8:41:26 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
30,676
30,676
-19,122
-99,964
-125,609
Investing Cash Flow
6,555
6,555
28,087
137,590
-76,903
Financing Cash Flow
-10,237
-10,237
-29,143
70,575
1,589
End Cash Position
166,821
166,821
140,324
161,705
56,304
Capital Expenditure
-235
-235
-2,480
-18,438
-14,202
Issuance of Capital Stock
--
--
-354
-753
-8,115
Issuance of Debt
33,162
33,162
11,426
77,491
12,040
Repayment of Debt
-38,123
-38,123
-35,211
-1,352
--
Repurchase of Capital Stock
-644
-644
-354
--
--
Free Cash Flow
30,441
30,441
-21,602
-118,402
-139,811
12/31/2021 - 2/3/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2QV0.F Chemomab Therapeutics Ltd.
1.0900
+2.83%
PBN.F Alterity Therapeutics Limited
0.0045
+12.50%
FAB.L Fusion Antibodies plc
6.80
-9.09%
TRMED.OL Thor Medical ASA
2.4000
-2.24%
ELIC.ST Elicera Therapeutics AB (publ)
4.3500
+13.73%
FARN.L Faron Pharmaceuticals Oy
202.00
-0.25%
BIOVIC-B.ST Biovica International AB (publ)
0.6980
+9.06%
MEDCL.PA MedinCell S.A.
14.97
+0.13%
VVY.AS Vivoryon Therapeutics N.V.
1.7760
-1.88%
SEOVF Sernova Biotherapeutics Inc
0.1400
-2.10%